Learning Objectives
Upon completion of this activity, participants should be able to:
- Define the criteria by which a patient is classified as castrate resistant
- Describe current treatment approaches for patients with castrate-resistant prostate cancer
- Explain factors to consider when choosing treatment options for castrate-resistant prostate cancer patients
- Cite novel research advances and therapeutic treatment options for the treatment of patients with castrate-resistant prostate cancer
Topics covered include:
- Introduction
- Definition of CRPC, Androgen-Independent Prostate Cancer, and Hormone-Refractory Prostate Cancer
- Influence of Metastatic Site on Treatment Course
- Optimal Androgen-Deprivation Therapy
- Value of Secondary Hormone Therapy: Who Are the Ideal Candidates?
- Current Treatment Approaches for CRPC
- Therapeutic Alternatives Following Docetaxel Failure
- Factors Influencing Choice of Treatment
- Nomograms for the Treatment of CRPC
- Future Strategies and Clinical Trial Data for CRPC
- Future Treatment Approaches for CRPC: Bone Targeting Strategies
- Immunotherapy for CRPC